According to INmune Bio's latest financial reports the company's current EPS (TTM) is -โน154.72. In 2022 the company made an earnings per share (EPS) of -โน129.93 an increase over its 2021 EPS that were of -โน160.71.
Year | EPS | Change |
---|---|---|
2024 (TTM) | -โน149.89 | |
2022 | -โน129.93 | -19.15% |
2021 | -โน160.71 | 86.14% |
2020 | -โน86.34 | 34.67% |
2019 | -โน64.11 | -32.36% |
2018 | -โน94.78 | 1396.12% |
2017 | -โน6.34 | 199.64% |
2016 | -โน2.11 |